Literature DB >> 10646507

Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.

L M Bohn1, M M Belcheva, C J Coscia.   

Abstract

As reports on G protein-coupled receptor signal transduction mechanisms continue to emphasize potential differences in signaling due to relative receptor levels and cell type specificities, the need to study endogenously expressed receptors in appropriate model systems becomes increasingly important. Here we examine signal transduction mechanisms mediated by endogenous kappa-opioid receptors in C6 glioma cells, an astrocytic model system. We find that the kappa-opioid receptor-selective agonist U69,593 stimulates phospholipase C activity, extracellular signal-regulated kinase 1/2 phosphorylation, PYK2 phosphorylation, and DNA synthesis. U69,593-stimulated extracellular signal-regulated kinase 1/2 phosphorylation is shown to be upstream of DNA synthesis as inhibition of signaling components such as pertussis toxin-sensitive G proteins, L-type Ca2+ channels, phospholipase C, intracellular Ca2+ release, protein kinase C, and mitogen-activated protein or extracellular signal-regulated kinase kinase blocks both of these downstream events. In addition, by overexpressing dominant-negative or sequestering mutants, we provide evidence that extracellular signal-regulated kinase 1/2 phosphorylation is Ras-dependent and transduced by Gbetagamma subunits. In summary, we have delineated major features of the mechanism of the mitogenic action of an agonist of the endogenous kappa-opioid receptor in C6 glioma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646507      PMCID: PMC2504523          DOI: 10.1046/j.1471-4159.2000.740564.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  68 in total

1.  The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors.

Authors:  L Y Li; K J Chang
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

2.  Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA.

Authors:  B B Ruzicka; C A Fox; R C Thompson; F Meng; S J Watson; H Akil
Journal:  Brain Res Mol Brain Res       Date:  1995-12-28

3.  Gi2-mediated activation of the MAP kinase cascade.

Authors:  A M Pace; M Faure; H R Bourne
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

4.  Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine.

Authors:  M T Berhow; N Hiroi; E J Nestler
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

5.  Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells.

Authors:  K Fukuda; S Kato; H Morikawa; T Shoda; K Mori
Journal:  J Neurochem       Date:  1996-09       Impact factor: 5.372

6.  Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.

Authors:  T Avidor-Reiss; I Nevo; R Levy; T Pfeuffer; Z Vogel
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

7.  Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase.

Authors:  S Eguchi; T Matsumoto; E D Motley; H Utsunomiya; T Inagami
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

8.  mu-Opioid receptor-induced Ca2+ mobilization and astroglial development: morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca(2+)-dependent mechanism.

Authors:  K F Hauser; A Stiene-Martin; M P Mattson; R P Elde; S E Ryan; C C Godleske
Journal:  Brain Res       Date:  1996-05-13       Impact factor: 3.252

9.  G(o)-protein alpha-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism.

Authors:  T van Biesen; B E Hawes; J R Raymond; L M Luttrell; W J Koch; R J Lefkowitz
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

10.  Coupling of ETB endothelin receptor to mitogen-activated protein kinase stimulation and DNA synthesis in primary cultures of rat astrocytes.

Authors:  F Lazarini; A D Strosberg; P O Couraud; S M Cazaubon
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

View more
  36 in total

1.  Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

Review 2.  Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Authors:  Mariana M Belcheva; Carmine J Coscia
Journal:  Neurosignals       Date:  2002 Jan-Feb

Review 3.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 4.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

5.  Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.

Authors:  Michael R Bruchas; Tara A Macey; Janet D Lowe; Charles Chavkin
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

6.  Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Authors:  Santhanalakshmi Sundaramurthy; Balasubramaniam Annamalai; Devadoss J Samuvel; Toni S Shippenberg; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Neuropharmacology       Date:  2016-10-12       Impact factor: 5.250

7.  Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.

Authors:  Kimberly M Lovell; Kevin J Frankowski; Edward L Stahl; Stephen R Slauson; Euna Yoo; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
Journal:  ACS Chem Neurosci       Date:  2015-05-01       Impact factor: 4.418

8.  Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.

Authors:  Selena S Schattauer; Andrea Bedini; Floyd Summers; Aiden Reilly-Treat; Mackenzie M Andrews; Benjamin B Land; Charles Chavkin
Journal:  J Biol Chem       Date:  2019-10-01       Impact factor: 5.157

Review 9.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

Review 10.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.